Withdrawal of Registration Statement (ammendment) (aw)
September 16 2019 - 4:17PM
Edgar (US Regulatory)
ANAVEX LIFE SCIENCES CORP.
51 W. 52nd Street, 7th Floor
New York, NY 10019-6163
September 16, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Re:
|
|
Anavex Life Sciences Corp.
|
|
|
Form AW - Request for Withdrawal
|
|
|
Amendment No. 4 to Registration Statement on Form S-3
|
|
|
File No. 333-207600
|
Ladies and Gentlemen:
Pursuant to Rule
477 under the Securities Act of 1933, as amended (the “Securities Act”), Anavex Life Sciences, Corp., a Nevada
corporation (the “Company”), hereby requests that the Securities and Exchange Commission (the “Commission”)
consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of Amendment No. 4 its
Registration Statement on Form S-3 (File No. 333-207600) (the “Amendment”), filed with the U.S. Securities
and Exchange Commission on September 13, 2019.
The grounds for
this application for withdrawal are that, subsequent to the filing of the Amendment, the Company determined that the Amendment
had been improperly tagged as a pre-effective amendment, rather than a post-effective amendment. As discussed with the Staff, the
Company requests withdrawal of the Amendment to permit the re-filing the Amendment properly tagged as a post-effective amendment.
No securities have
been sold under the registration statement of which the Amendment is a part.
Please direct any
questions or comments regarding this filing to Clayton Parker, Esq. at (305) 794-6293 of K&L Gates LLP, legal counsel to the
Company.
|
Sincerely,
|
|
|
|
/s/ Christopher Missling, PhD
|
|
Christopher Missling, PhD
Chief Executive Officer
|
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Apr 2023 to Apr 2024